Tubulin Inhibitors for Breast Cancer Market
This report contains market size and forecasts of Tubulin Inhibitors for Breast Cancer in Global, ... Read More
This report contains market size and forecasts of Fulvestrant in global, including the following market information:
Global Fulvestrant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fulvestrant Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Fulvestrant companies in 2021 (%)
The global Fulvestrant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1 Injection/Box Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fulvestrant include Teva, Amneal Pharms, AstraZeneca, Novartis, Intas Pharmaceuticals, Chemo, Accure Labs and Natco, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fulvestrant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fulvestrant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Fulvestrant Market Segment Percentages, by Type, 2021 (%)
1 Injection/Box
2 Injection/Box
Global Fulvestrant Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Fulvestrant Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Fulvestrant Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Fulvestrant Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fulvestrant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fulvestrant revenues share in global market, 2021 (%)
Key companies Fulvestrant sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Fulvestrant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Amneal Pharms
AstraZeneca
Novartis
Intas Pharmaceuticals
Chemo
Accure Labs
Natco
This report contains market size and forecasts of Tubulin Inhibitors for Breast Cancer in Global, ... Read More
This report contains market size and forecasts of PARP Inhibitors for Breast Cancer in Global, in ... Read More
This report contains market size and forecasts of VEGF Targeted Drugs for Breast Cancer in Global ... Read More
This report contains market size and forecasts of PI3K/AKT/mTor Pathway Inhibitors for Breast Can ... Read More